Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes

被引:46
作者
Diomede, L [1 ]
Sozzani, S [1 ]
Luini, W [1 ]
Algeri, M [1 ]
DeGioia, L [1 ]
Chiesa, R [1 ]
Lievens, PMJ [1 ]
Bugiani, O [1 ]
Forloni, G [1 ]
Tagliavini, F [1 ]
Salmona, M [1 ]
机构
[1] IST NEUROCHIRURG C BESTA,I-20133 MILAN,ITALY
关键词
D O I
10.1042/bj3200563
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion-related encephalopathies are characterized by the intracerebral accumulation of an abnormal isoform of the cellular prion protein (PrPc) named scrapie prion protein (PrPSc). The pathological forms of this protein and its cellular precursor are not only expressed in the brain but also, at lower concentrations, in peripheral tissues. We recently showed that a synthetic peptide corresponding to residues 106-126 [PrP-(106-126)] of the human PrP is toxic to neurons and trophic to astrocytes in vitro. Our experiments were aimed at verifying whether PrP-(106-126) and other peptides corresponding to fragments of the amyloid protein purified from brains of patients with Gerstmann-Straussler-Scheinker disease-namely PrP-(89-106), PrP-(106-114), PrP(127-147)- were capable of stimulating circulating leucocytes. Native PrP expression in human lymphocytes, monocytes and neutrophils was first confirmed using PCR amplification of total RNA, after reverse transcription, and immunoblot analysis of cell extracts with anti-PrP antibodies. PrP-(106-126), but not the other peptides, increased membrane microviscosity, intracellular Ca2+ concentration and cell migration in circulating leucocytes, and O-2(-*) production in monocytes and neutrophils. Membrane microviscosity was determined by the fluorescence polarization technique, using diphenylhexatriene as a probe, 300 s after the addition of PrP-(106-126) to the cell suspension in the concentration range 5-50 mu M. The increase in intracellular Ca2+ elicited by PrP-(106-126) was dose-dependent in the range 5-500 mu M. PrP-(106-126) stimulated O-2(-*) production in monocytes and neutrophils in a dose- (10-300 mu M) and time (5-30 min) dependent manner in the presence of 10 mu M dihydrocytochalasin B. Both the increase in Ca2+ concentration and the O-2(-*) production were partially sensitive to pertussis toxin. PrP-(106-126) stimulated leucocyte migration in a dose-dependent (30-300 mu M) manner and, at the highest concentration used, this migration was comparable with that elicited by 2.5 nM interleukin 8 or 10 nM fMet-Leu-Phe peptide.
引用
收藏
页码:563 / 570
页数:8
相关论文
共 36 条
  • [21] SIZE AND INTRACELLULAR LOCATION OF SCRAPIE AGENT
    HUNTER, GD
    [J]. BIOCHEMICAL JOURNAL, 1969, 114 (02) : P22 - &
  • [22] KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1
  • [23] MOLECULAR-CLONING OF A HUMAN PRION PROTEIN CDNA
    KRETZSCHMAR, HA
    STOWRING, LE
    WESTAWAY, D
    STUBBLEBINE, WH
    PRUSINER, SB
    DEARMOND, SJ
    [J]. DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1986, 5 (04): : 315 - 324
  • [24] SCRAPIE PRIONS ALTER RECEPTOR-MEDIATED CALCIUM RESPONSES IN CULTURED-CELLS
    KRISTENSSON, K
    FEUERSTEIN, B
    TARABOULOS, A
    HYUN, WC
    PRUSINER, SB
    DEARMOND, SJ
    [J]. NEUROLOGY, 1993, 43 (11) : 2335 - 2341
  • [25] A MUTANT PRION PROTEIN DISPLAYS AN ABERRANT MEMBRANE ASSOCIATION WHEN EXPRESSED IN CULTURED-CELLS
    LEHMANN, S
    HARRIS, DA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) : 24589 - 24597
  • [26] ACTIVATION OF MICROGLIAL CELLS BY BETA-AMYLOID PROTEIN AND INTERFERON-GAMMA
    MEDA, L
    CASSATELLA, MA
    SZENDREI, GI
    OTVOS, L
    BARON, P
    VILLALBA, M
    FERRARI, D
    ROSSI, F
    [J]. NATURE, 1995, 374 (6523) : 647 - 650
  • [27] PRESENCE OF PRION PROTEIN IN PERIPHERAL-TISSUES OF LIBYAN JEWS WITH CREUTZFELDT-JAKOB DISEASE
    MEINER, Z
    HALIMI, M
    POLAKIEWICZ, RD
    PRUSINER, SB
    GABIZON, R
    [J]. NEUROLOGY, 1992, 42 (07) : 1355 - 1360
  • [28] CYTOPROTECTIVE EFFECT OF NMDA RECEPTOR ANTAGONISTS ON PRION PROTEIN (PRION(SC))-INDUCED TOXICITY IN RAT CORTICAL CELL-CULTURES
    MULLER, WEG
    USHIJIMA, H
    SCHRODER, HC
    FORREST, JMS
    SCHATTON, WFH
    RYTIK, PG
    HEFFNERLAUC, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 246 (03): : 261 - 267
  • [29] Prion protein released by platelets
    Perini, F
    Frangione, B
    Prelli, F
    [J]. LANCET, 1996, 347 (9015) : 1635 - 1636
  • [30] MOLECULAR-BIOLOGY OF PRION DISEASES
    PRUSINER, SB
    [J]. SCIENCE, 1991, 252 (5012) : 1515 - 1522